Graphene Oxide Based Fluorescent DNA Aptasensor for Liver Cancer Diagnosis and Therapy
Ke Ma, Wei Xie, Wei Liu, Lei Wang, Dong Wang, Ben Zhong Tang
Abstract
Abstract Graphene oxide (GO)‐based fluorescent DNA aptasensors are promising nanomaterials in bioassays owing to the fluorescent ultrasensitivity and target identification ability. However, their in vivo application remains an appealing yet significantly challenging task. In this contribution, for the first time, a nanomaterial for in vivo diagnosis and therapy of liver tumors is demonstrated. A DNA nanomaterial consisting of DNA tetrahedron and aptamers, aggregation‐induced emission luminogens, and antitumor drug doxorubicin, is fabricated and attached on the GO surface. This developed hybrid with good biocompatibility exhibits high selectivity to target liver cancer cells, and performs well in in vitro and in vivo liver tumor fluorescence imaging diagnosis and chemotherapy. Additionally, a GO‐based fluorescent DNA nanodevice is also constructed by using microfluidic chips for liver tumor cell screening.